Oral Antibiotic Exposure and Kidney Stone Disease

Total Page:16

File Type:pdf, Size:1020Kb

Oral Antibiotic Exposure and Kidney Stone Disease CLINICAL EPIDEMIOLOGY www.jasn.org Oral Antibiotic Exposure and Kidney Stone Disease Gregory E. Tasian,1,2,3 Thomas Jemielita,4 David S. Goldfarb,5 Lawrence Copelovitch,6 Jeffrey S. Gerber,2,3,7 Qufei Wu,3 and Michelle R. Denburg2,3,6 1Division of Pediatric Urology, Department of Surgery, and 2Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; 3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; 4Biostatistics and Research Decision Science, Early Oncology Department, Merck & Co., Inc., North Wales, Pennsylvania; 5Division of Nephrology, Department of Medicine, New York University Langone Medical Center, New York, New York; and Divisions of 6Nephrology and 7Infectious Diseases, Department of Pediatrics, The Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania ABSTRACT Background Although intestinal and urinary microbiome perturbations are associated with nephrolithia- sis, whether antibiotics are a risk factor for this condition remains unknown. Methods We determined the association between 12 classes of oral antibiotics and nephrolithiasis in a population-based, case–control study nested within 641 general practices providing electronic health record data for .13 million children and adults from 1994 to 2015 in the United Kingdom. We used in- cidence density sampling to match 25,981 patients with nephrolithiasis to 259,797 controls by age, sex, and practice at date of diagnosis (index date). Conditional logistic regression models were adjusted for the rate of health care encounters, comorbidities, urinary tract infections, and use of thiazide and loop di- uretics, proton-pump inhibitors, and statins. Results Exposure to any of five different antibiotic classes 3–12 months before index date was associated with nephrolithiasis. The adjusted odds ratio (95% confidence interval) was 2.33 (2.19 to 2.48) for sulfas, 1.88 (1.75 to 2.01) for cephalosporins, 1.67 (1.54 to 1.81) for fluoroquinolones, 1.70 (1.55 to 1.88) for nitrofurantoin/methenamine, and 1.27 (1.18 to 1.36) for broad-spectrum penicillins. In exploratory analy- ses, the magnitude of associations was greatest for exposure at younger ages (P,0.001) and 3–6months before index date (P,0.001), with all but broad-spectrum penicillins remaining statistically significant 3–5 years from exposure. CLINICAL EPIDEMIOLOGY Conclusions Oral antibiotics associated with increased odds of nephrolithiasis, with the greatest odds for recent exposure and exposure at younger age. These results have implications for disease pathogenesis and the rising incidence of nephrolithiasis, particularly among children. J Am Soc Nephrol 29: 1731–1740, 2018. doi: https://doi.org/10.1681/ASN.2017111213 Prior studies have reported associations between extracted from patients without urinary tract infec- antibiotic exposure and diseases such as inflamma- tion (UTI), suggesting a role for selective pressure tory bowel disease and asthma.1,2 These associa- on the urinary microbiome in kidney stone tions are thought to be mediated by disruption of the human microbiome. Received November 22, 2017. Accepted March 25, 2018. It is biologically plausible that antibiotics may Published online ahead of print. Publication date available at increase the risk of nephrolithiasis. Recent studies www.jasn.org. reported differences in the composition of the in- Correspondence: Dr. Gregory Edward Tasian, Division of Urol- testinal microbiome between patients with and ogy, Children’s Hospital of Philadelphia, Wood Center, 3rd Floor, without nephrolithiasis.3,4 Additionally, multidrug 34th Street and Civic Center Boulevard, Philadelphia, PA 19104. resistant nonurease-producing bacteria have been Email: [email protected] isolated from calcium-based kidney stones Copyright © 2018 by the American Society of Nephrology J Am Soc Nephrol 29: 1731–1740, 2018 ISSN : 1046-6673/2906-1731 1731 CLINICAL EPIDEMIOLOGY www.jasn.org formation.5 However, despite the well established effect that Significance Statement antibiotics have on the microbiome, it remains unclear whether antibiotics are a risk factor for nephrolithiasis. This Kidney stones are a disorder of crystallization related to the su- information would have important implications for elucidat- persaturation of solutes in urine. For reasons that remain ill-defined, ing causal pathways for kidney stone formation, understand- the prevalence has increased 70% over the past 30 years. Pertur- bations in the intestinal and urinary microbiome are associated with ing the increase in the prevalence of nephrolithiasis (most nephrolithiasis, but it is uncertain whether antibiotics are a risk factor pronounced among children, adolescents, and young for nephrolithiasis. This article reports that oral cephalosporins, adults),6,7 and promoting antibiotic stewardship. fluoroquinolones, sulfas, nitrofurantoin, and broad-spectrum peni- In this nested case–control study, we evaluated the associ- cillins are associated with increased adjusted odds of nephrolithiasis ation between oral antibiotic exposure and nephrolithiasis, among children and adults. The greatest risk was estimated for prescriptions at younger ages and for more recent exposures. Ex- and assessed its strength and temporality by antibiotic class. posure to some oral antibiotics may represent a novel risk factor for Because prior murine studies demonstrated a greater effect of nephrolithiasis and might contribute to the rising incidence of kidney early-life antibiotic exposure on host metabolism,8 we hy- stones, particularly among children. pothesized that exposure to oral antibiotics at younger ages would be associated with a greater risk of nephrolithiasis. associations between nephrolithiasis and hypertension and CKD12 similar to those reported in prospective cohort METHODS studies that ascertained nephrolithiasis through validated self-report.13,14 Patients ,90 years old without Read codes for nephroli- Study Design thiasis, bladder calculi, renal colic, hypercalciuria, or nephro- We conducted a population-based, nested case–control study, calcinosis before the index date were eligible for selection using the February 2015 version of The Health Improvement as controls. Ten controls were matched on age, sex, and GP Network (THIN). THIN comprises data from 13.8 million practice to each case at their index date by incidence density individuals receiving care in 641 general practitioner (GP) sampling. practices in the United Kingdom from 1994 to 2015. These patients are representative of the United Kingdom population by age, sex, medical conditions, and death rates. Practices Exposure enter clinical data for each patient encounter, generating a The primary exposure was an outpatient oral antibiotic pre- – longitudinal, patient-level record that includes outpatient pre- scribed 3 12 months before the index date. This period was scriptions. Diagnoses and procedures are recorded with Read selected because kidney stones form over weeks to months and codes, the standard classification system in the United King- oral antibiotics cause changes in the quantity and composition 15 dom. THIN facilitates population-based pharmacoepidemio- of the microbiome for months after exposure. Patients who logic studies because approximately 98% of the United had antibiotic prescriptions within 3 months of the index date Kingdom population is registered with a GP practice,9 and were not considered exposed to mitigate exposure misclassi- fi GPs have nearly exclusive prescribing rights within the Na- cation (e.g., antibiotics recorded before the nephrolithiasis tional Health Service. This study was determined by the Uni- diagnosis were actually prescribed afterward) and because an- versity of Pennsylvania Institutional Review Board to meet tibiotics may have been prescribed for symptoms related to criteria for institutional review board exemption. stone presentations (e.g., dysuria or pyuria on urinalysis). Antibiotics were categorized as cephalosporins, fluoroqui- Study Population and Outcome nolones, lincosamides, macrolides, metronidazole, nitrofur- The outcome was nephrolithiasis diagnosis. Tobe considered a antoin/methenamine, penicillins, broad-spectrum penicillins, case, an individual had to be ,90 years old and registered with sulfas, tetracyclines, and antimycobacterial drugs (see Supple- his/her GP practice for 6 months before the first qualifying mental Table 2 for drugs in each antibiotic class). We also code for nephrolithiasis. Although this approach has been val- examined Helicobacter pylori treatment, because it is explicitly fi idated for ascertainment of incident diagnoses in THIN, it has identi ed in THIN and prior studies reported decreased in- not been validated for nephrolithiasis, which can be charac- testinal colonization by Oxalobacter 6 months after H. pylori 16 terized by recurrent acute episodes.10 Patients who only had treatment. Prescriptions for each antibiotic of any duration codes for renal colic, hypercalciuria, or nephrocalcinosis and dosage within the exposure window was evaluated as a were not considered to have nephrolithiasis. The date of neph- binary variable. rolithiasis diagnosis (index date) was the date that the first qualifying code for nephrolithiasis was recorded (see Supple- Covariates mental Table 1 for nephrolithiasis codes).11,12 Patients with For each individual, we identified prevalent
Recommended publications
  • Medical Review(S) Clinical Review
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 200327 MEDICAL REVIEW(S) CLINICAL REVIEW Application Type NDA Application Number(s) 200327 Priority or Standard Standard Submit Date(s) December 29, 2009 Received Date(s) December 30, 2009 PDUFA Goal Date October 30, 2010 Division / Office Division of Anti-Infective and Ophthalmology Products Office of Antimicrobial Products Reviewer Name(s) Ariel Ramirez Porcalla, MD, MPH Neil Rellosa, MD Review Completion October 29, 2010 Date Established Name Ceftaroline fosamil for injection (Proposed) Trade Name Teflaro Therapeutic Class Cephalosporin; ß-lactams Applicant Cerexa, Inc. Forest Laboratories, Inc. Formulation(s) 400 mg/vial and 600 mg/vial Intravenous Dosing Regimen 600 mg every 12 hours by IV infusion Indication(s) Acute Bacterial Skin and Skin Structure Infection (ABSSSI); Community-acquired Bacterial Pneumonia (CABP) Intended Population(s) Adults ≥ 18 years of age Template Version: March 6, 2009 Reference ID: 2857265 Clinical Review Ariel Ramirez Porcalla, MD, MPH Neil Rellosa, MD NDA 200327: Teflaro (ceftaroline fosamil) Table of Contents 1 RECOMMENDATIONS/RISK BENEFIT ASSESSMENT ......................................... 9 1.1 Recommendation on Regulatory Action ........................................................... 10 1.2 Risk Benefit Assessment.................................................................................. 10 1.3 Recommendations for Postmarketing Risk Evaluation and Mitigation Strategies ........................................................................................................................
    [Show full text]
  • Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and Its Application
    Infect Dis Ther (2017) 6:57–67 DOI 10.1007/s40121-016-0144-8 REVIEW Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application Juwon Yim . Leah M. Molloy . Jason G. Newland Received: November 10, 2016 / Published online: December 30, 2016 Ó The Author(s) 2016. This article is published with open access at Springerlink.com ABSTRACT infections, CABP caused by penicillin- and ceftriaxone-resistant S. pneumoniae and Ceftaroline is a novel cephalosporin recently resistant Gram-positive infections that fail approved in children for treatment of acute first-line antimicrobial agents. However, bacterial skin and soft tissue infections and limited data are available on tolerability in community-acquired bacterial pneumonia neonates and infants younger than 2 months (CABP) caused by methicillin-resistant of age, and on pharmacokinetic characteristics Staphylococcus aureus, Streptococcus pneumoniae in children with chronic medical conditions and other susceptible bacteria. With a favorable and those with invasive, complicated tolerability profile and efficacy proven in infections. In this review, the microbiological pediatric patients and excellent in vitro profile of ceftaroline, its mechanism of action, activity against resistant Gram-positive and and pharmacokinetic profile will be presented. Gram-negative bacteria, ceftaroline may serve Additionally, clinical evidence for use in as a therapeutic option for polymicrobial pediatric patients and proposed place in therapy is discussed. Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 1F47F0601BB3F2DD. Keywords: Antibiotic resistance; Ceftaroline J. Yim (&) fosamil; Children; Methicillin-resistant St. John Hospital and Medical Center, Detroit, MI, Staphylococcus aureus; Streptococcus pneumoniae USA e-mail: [email protected] L.
    [Show full text]
  • Prevalence of Self-Medication of Antibiotics Among People In
    International Journal of Pharmacy Teaching & Practices 2013, Vol.4, Issue 1, 504-510. Prevalence of self-medication of antibiotics among people in Bangladesh Nishat Chowdhury*, Mohammad Rashedul Islam, Md. Mehedi Hasan, Md. Mahmudur Rouf *Department of Pharmacy, State University of Bangladesh, Dhanmondi, Dhaka, Bangladesh Introduction Research Article Widespread and inappropriate use of antibiotics increases health care costs (1) and contributes to Please cite this paper as: Nishat Chowdhury*, Mohammad Rashedul Islam, Md. Mehedi Hasan, Md. Mahmudur Rouf. Prevalence of self- antibiotic resistance (2)。 Antimicrobial medication medication of antibiotics among people in Bangladesh . IJPTP, 2013, management in Bangladesh has been highlighted by 4(1), 504-510. previous studies as an area for improvement (3). Corresponding Author: There is already enough evidence of growing resistance to antimicrobials in this country resulting Nishat Chowdhury, from misuse (4-6). Previous study showed that Department of Pharmacy, State University of Bangladesh, antimicrobials are widely available (18% incidents) in Dhanmondi, Dhaka, Bangladesh the home medicine cabinets of the Dhaka City Telephone -88028612992, population (7). Since there is no prescription-only Email: [email protected] drug in Bangladesh, people can purchase drugs like sedatives, antimicrobials without prescription even in the remote parts of the country (8-9). The relative Abstract lack of data on the morbidity and mortality attributable to antibiotic resistance, including the This study attempts to investigate the prevalence of self- economic impact on individuals as well as on health medication of antibiotics among people in Bangladesh.This care and societies, may explain the weak reaction study was conducted in six districts of Bangladesh (Dhaka, from politicians, public health workers, and Munshiganj, Kishoreganj, Chittagong, Chandpur, Kushtia) by consumers to this threat to public health (10).
    [Show full text]
  • Histological Tumour Type (Required)
    Histological tumour type (Required) Reason/Evidentiary Support All ovarian epithelial malignancies and borderline tumours should be typed according to the WHO classification.1 There are 5 major subtypes of primary ovarian carcinoma, high‐grade serous, clear cell, endometrioid, mucinous and low‐ grade serous.2‐5 There are also other uncommon minor subtypes, those listed by the WHO including malignant Brenner tumour, seromucinous carcinoma and undifferentiated carcinoma.1 Carcinosarcoma is a mixed epithelial and mesenchymal malignancy but is included in the category of epithelial malignancies in this dataset since most are of epithelial origin and histogenesis.6 Although management of ovarian carcinoma is, at present, largely dependent on tumour stage and grade, accurate typing will almost certainly become more important in the future with the introduction of targeted therapies and specific treatments for different tumour types. This is in part because, although clinically often considered as one disease, there is an increasing realisation that the different morphological subtypes of ovarian carcinoma have a different pathogenesis, are associated with distinct molecular alterations and have a different natural history, response to traditional chemotherapy and prognosis.2‐5 Tumour typing may also be important in identifying or initiating testing for an underlying genetic predisposition; for example, high‐grade serous carcinoma may be associated with underlying BRCA1/2 mutation while endometrioid and clear cell carcinomas can occur in patients with Lynch syndrome.7 The most common ovarian carcinoma is high‐grade serous carcinoma (approximately 70%) followed by clear cell and endometrioid.8,9 Mucinous and low‐grade serous are less common. Approximately 90% of advanced stage ovarian carcinomas (stage III/IV) are high‐grade serous in type.8,9 Most primary tubal carcinomas are high‐grade serous or endometrioid and most primary peritoneal carcinomas are of high‐grade serous type.
    [Show full text]
  • Anthem Blue Cross Drug Formulary
    Erythromycin/Sulfisoxazole (generic) INTRODUCTION Penicillins ...................................................................... Anthem Blue Cross uses a formulary Amoxicillin (generic) (preferred list of drugs) to help your doctor Amoxicillin/Clavulanate (generic/Augmentin make prescribing decisions. This list of drugs chew/XR) is updated quarterly, by a committee Ampicillin (generic) consisting of doctors and pharmacists, so that Dicloxacillin (generic) the list includes drugs that are safe and Penicillin (generic) effective in the treatment of diseases. If you Quinolones ..................................................................... have any questions about the accessibility of Ciprofloxacin/XR (generic) your medication, please call the phone number Levofloxacin (Levaquin) listed on the back of your Anthem Blue Cross Sulfonamides ................................................................ member identification card. Erythromycin/Sulfisoxazole (generic) In most cases, if your physician has Sulfamethoxazole/Trimethoprim (generic) determined that it is medically necessary for Sulfisoxazole (generic) you to receive a brand name drug or a drug Tetracyclines .................................................................. that is not on our list, your physician may Doxycycline hyclate (generic) indicate “Dispense as Written” or “Do Not Minocycline (generic) Substitute” on your prescription to ensure Tetracycline (generic) access to the medication through our network ANTIFUNGAL AGENTS (ORAL) _________________ of community
    [Show full text]
  • Angiomyolipoma of the Cervix – Report of a Rare Entity
    Internet Journal of Medical Update. 2017 July;12(2):13-15. doi: 10.4314/ijmu.v12i2.4 Internet Journal of Medical Update Journal home page: http://www.akspublication.com/ijmu Case Report Angiomyolipoma of the cervix – report of a rare entity N. Hariharanadha Sarmaᴪ1, Rama Srivastava2, Smriti Agnihotri3 1Consultant Pathologist, Department of Pathology, RDT Hospital, Bathalapalli, Andhra Pradesh, India 2Professor, Department of Pathology, SSR Medical College, Belle Rive, Mauritius 3Professor, Department of Pathology, American University of Antigua College of Medicine, Antigua & Barbuda, WI (Received 22 September 2017 and accepted 04 October 2017) ABSTRACT: Angiomyolipoma (AML) is a mesenchymal neoplasm seen usually in the kidney. Few cases of extra renal AML have been documented in various organs including the female genital tract, where the uterus is the most common site. To the best of our knowledge, only 4 cases of AML in the cervix have been reported in the literature. Association of AML with tuberous sclerosis is well known. Presently AML is included in the spectrum of disease entities called PEComa. We report a case of AML without tuberous sclerosis arising from the uterine cervix, which has to be differentiated from lipoleiomyoma. KEY WORDS: Angiomyolipoma; Uterine cervix; PEComas; Uterine tumor INTRODUCTIONV localization8, and mostly in females over 409. The occurrence of AML in the cervix without Angiomyolipoma (AML) occurs most frequently in concurrent incidence in the kidney is extremely the kidney, where it is closely related to tuberous rare, and only four cases have been reported in the sclerosis complex (TSC)1,2, occasionally in other scientific literature10. We are reporting a case of organs, most commonly the liver, but occurrence at uterine cervix AML without tuberous sclerosis other sites is extremely rare3.
    [Show full text]
  • Soft Tissue Cytopathology: a Practical Approach Liron Pantanowitz, MD
    4/1/2020 Soft Tissue Cytopathology: A Practical Approach Liron Pantanowitz, MD Department of Pathology University of Pittsburgh Medical Center [email protected] What does the clinician want to know? • Is the lesion of mesenchymal origin or not? • Is it begin or malignant? • If it is malignant: – Is it a small round cell tumor & if so what type? – Is this soft tissue neoplasm of low or high‐grade? Practical diagnostic categories used in soft tissue cytopathology 1 4/1/2020 Practical approach to interpret FNA of soft tissue lesions involves: 1. Predominant cell type present 2. Background pattern recognition Cell Type Stroma • Lipomatous • Myxoid • Spindle cells • Other • Giant cells • Round cells • Epithelioid • Pleomorphic Lipomatous Spindle cell Small round cell Fibrolipoma Leiomyosarcoma Ewing sarcoma Myxoid Epithelioid Pleomorphic Myxoid sarcoma Clear cell sarcoma Pleomorphic sarcoma 2 4/1/2020 CASE #1 • 45yr Man • Thigh mass (fatty) • CNB with TP (DQ stain) DQ Mag 20x ALT –Floret cells 3 4/1/2020 Adipocytic Lesions • Lipoma ‐ most common soft tissue neoplasm • Liposarcoma ‐ most common adult soft tissue sarcoma • Benign features: – Large, univacuolated adipocytes of uniform size – Small, bland nuclei without atypia • Malignant features: – Lipoblasts, pleomorphic giant cells or round cells – Vascular myxoid stroma • Pitfalls: Lipophages & pseudo‐lipoblasts • Fat easily destroyed (oil globules) & lost with preparation Lipoma & Variants . Angiolipoma (prominent vessels) . Myolipoma (smooth muscle) . Angiomyolipoma (vessels + smooth muscle) . Myelolipoma (hematopoietic elements) . Chondroid lipoma (chondromyxoid matrix) . Spindle cell lipoma (CD34+ spindle cells) . Pleomorphic lipoma . Intramuscular lipoma Lipoma 4 4/1/2020 Angiolipoma Myelolipoma Lipoblasts • Typically multivacuolated • Can be monovacuolated • Hyperchromatic nuclei • Irregular (scalloped) nuclei • Nucleoli not typically seen 5 4/1/2020 WD liposarcoma Layfield et al.
    [Show full text]
  • Practical Veterinary Dermatopathology for the Small Animal Clinician
    Dermatopathology_FINAL.qxd 2/14/06 11:19 AM Page i Practical Veterinary Dermatopathology for the Small Animal Clinician Sonya V. Bettenay, BVSc Dip. Ed, MACVSc, FACVSc CSU Diagnostic Laboratory Dermatopathology Service Department of Clinical Sciences Colorado State University Fort Collins, CO Ann M. Hargis, DVM, MS Diplomate, ACVP DermatoDiagnostics, Edmonds, WA Department of Comparative Medicine University of Washington, Seattle, WA Phoenix Central Laboratory Everett, WA Jackson,Wyoming www.veterinarywire.com Teton NewMedia Teton NewMedia 90 East Simpson, Suite 110 Jackson, WY 83001 © 2003 by Tenton NewMedia Exclusive worldwide distribution by CRC Press an imprint of Taylor & Francis Group, an Informa business Version Date: 20140103 International Standard Book Number-13: 978-1-4822-4128-0 (eBook - PDF) This book contains information obtained from authentic and highly regarded sources. While all reasonable efforts have been made to publish reliable data and information, neither the author[s] nor the publisher can accept any legal responsibility or liability for any errors or omissions that may be made. The publishers wish to make clear that any views or opinions expressed in this book by individual editors, authors or contributors are personal to them and do not necessarily reflect the views/opinions of the publishers. The information or guidance contained in this book is intended for use by medical, scientific or health-care professionals and is provided strictly as a supplement to the medical or other professional’s own judgement, their knowledge of the patient’s medical history, relevant manufacturer’s instructions and the appropriate best practice guide- lines. Because of the rapid advances in medical science, any information or advice on dosages, procedures or diagnoses should be independently verified.
    [Show full text]
  • Surgical Treatment of Urinary Incontinence in Men
    Committee 13 Surgical Treatment of Urinary Incontinence in Men Chairman S. HERSCHORN (Canada) Members H. BRUSCHINI (Brazil), C.COMITER (USA), P.G RISE (France), T. HANUS (Czech Republic), R. KIRSCHNER-HERMANNS (Germany) 1121 CONTENTS I. INTRODUCTION VIII. TRAUMATIC INJURIES OF THE URETHRA AND PELVIC FLOOR II. EVALUATION PRIOR TO SURGICAL THERAPY IX. CONTINUING PEDIATRIC III. INCONTINENCE AFTER RADICAL PROBLEMS INTO ADULTHOOD: THE PROSTATECTOMY FOR PROSTATE EXSTROPHY-EPISPADIAS COMPLEX CANCER X. DETRUSOR OVERACTIVITY AND IV. INCONTINENCE AFTER REDUCED BLADDER CAPACITY PROSTATECTOMY FOR BENIGN DISEASE XI. URETHROCUTANEOUS AND V. SURGERY FOR INCONTINENCE IN RECTOURETHRAL FISTULAE ELDERLY MEN VI. INCONTINENCE AFTER XII. THE ARTIFICIAL URINARY EXTERNAL BEAM RADIOTHERAPY SPHINCTER (AUS) ALONE AND IN COMBINATION WITH SURGERY FOR PROSTATE CANCER XIII. SUMMARY AND RECOMMENDATIONS VII. INCONTINENCE AFTER OTHER TREATMENT FOR PROSTATE CANCER REFERENCES 1122 Surgical Treatment of Urinary Incontinence in Men S. HERSCHORN, H. BRUSCHINI, C. COMITER, P. GRISE, T. HANUS, R. KIRSCHNER-HERMANNS high-intensity focused ultrasound, other pelvic I. INTRODUCTION operations and trauma is a particularly challenging problem because of tissue damage outside the lower Surgery for male incontinence is an important aspect urinary tract. The artificial sphincter implant is the of treatment with the changing demographics of society most widely used surgical procedure but complications and the continuing large numbers of men undergoing may be more likely than in other areas and other surgery and other treatments for prostate cancer. surgical approaches may be necessary. Unresolved problems from pediatric age and patients with Basic evaluation of the patient is similar to other areas refractory incontinence from overactive bladders may of incontinence and includes primarily a clinical demand a variety of complex reconstructive surgical approach with history, frequency-volume chart or procedures.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Aderomyoma of the Common Bile Duct --Report of a Case
    Yamanashl Med. J. 4 (2), 83"v87, 1989 Case Report AdeRomyoma of the Common Bile Duct --Report of a Case Yoshiro MATsuMoTe, Masatoshi MoGAKi, Hidehisa AoyAMA, Takayoshi SEKmAwA, Katsnhiko SuGAHARA, Koichi SuDAi), and Masayuki FuJiNo2) DePa,rt・ment of Surge7pu. i)DePartment of Pathology, 2)DePartment of lnte7"nal Medicine, YamanasJzi Medical Coglege, Tamaho, Nakakoma, Ya?nanashi 409-38, JaPan Abstract: Adenomyomas in the extrahepatic biie duc£ are extremely rare. In a 75-year- old male with acute cholangitis due to adenomyoma £erming a protruding lesion iR the terminal bile duct, pamacreatoduodenectomy was carried out, resulting complete cure, Key words: Adenomyoma of the common bile duct, Early bile dact cancer, Obstructive jaundice formed, aRd £rom the histologic examina- INTRODUCTION tion of the surgical specimen, adenomyoma Adenomyoma in the biliary ductal system of the common bile duct was confirmed. is most freguently fouRd in the gallbladder. Although beRign neoplasma o£ the bile The gallbiadder wall is more abuRdant in duct system are uncommon, the tumors are muscle fibers than is the wall o£ the bile clinically very important because they can duct. Adenomyoma in the gallbladder is cause obstructive jaundice4) and require knowlt to be closely re}ated to the forma- differentiation £rom eary cancer of the bile tion of gallstones. In other parts of the duct. biliary ductal system, kex4xeve]-, adeno- We report here the surgical results and myoma is very rarei)・2), although a few pathologic findings in a case of adeno- cases of a tumor arising from the papil}a myoma of the terminal bile duct. of Vater3) have beelt reported.
    [Show full text]